A sensitive and reproducible HPLC assay for doxorubicin and pirarubicin.
A high-performance liquid chromatographic method with spectrofluorometric detection has been developed for the analysis of doxorubicin (DOX), pirarubicin (PIRA) and their metabolite, doxorubicinol, in plasma. The detection was performed at 480 nm for excitation, and 590 nm for emission. The proposed technique is selective, reliable, and sensitive. The limit of quantification was 2 ng ml-1 for DOX and 5 ng ml-1 for PIRA. The reproducibility of the analytical method through statistical coefficients is approximately 5%. The accuracy of the method is good; the relative error is less than 5%.
Jacquet
J M
JM
Laboratoire Universitaire de Thérapeutique, Faculté de Médecine, CHRU Nîmes, France.
Galtier
M
M
Bressolle
F
F
Jourdan
J
J
D000903:Antibiotics, Antineoplastic / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000032:analysis*
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; C027260:pirarubicin